BIOVILL Co.,Ltd. announced that it has received KRW 25 billion in funding from KB Securities Co., Ltd., Investment Arm
January 04, 2018
Share
BIOVILL Co.,Ltd. (KOSDAQ:A065940) announced a private placement of 10th series unregistered and unsecured private convertible bonds for proceeds of KRW 25,000,000,000 on January 5, 2018. The transaction includes participation from KB Securities Co., Ltd., Investment Arm. The bonds carry a interest rate of 1% per annum. The 10th series bonds are issued at par and have yield to maturity of 4% and would mature on January 5, 2023. The bonds are convertible into 6,787,944 shares of the company at a fixed conversion price of KRW 3,683 per share between the periods of January 5, 2019 to December 5, 2022. The subscription date is January 5, 2018. The transaction has been approved by the board of directors of the company.
BIOVILL Co.,Ltd., formerly KSCB Co.,Ltd. is a Korea-based company mainly engaged in the manufacture of pigment preparations used in plastic processing industry. The Company provides four categories of products: plastic coloring agents, plastic printing inks, synthetic leather surface coating agents and polyvinyl chloride (PVC) compounds. Its products are used in construction, automobile, advertising, electronic and other industries. In addition, it also involves in the provision of pigments and solvents. Through its subsidiaries, the Company is also engaged in the stem cell business.
KSCB CO LTD 
